Explaining the decline in coronary heart disease mortality in the Czech Republic between 1985 and 2007

European Journal of Preventive Cardiology

Volumn 21, Issue 7, 2014, Pages 829-839

  Bruthans, Jan ^a,b   Cífková, Renata ^a,b,c,d   Lánská, Vera ^a   O'Flaherty, Martin ^e   Critchley, Julia A ^f   Holub, Jiří ^g   Janský, Petr ^h   Zvárová, Jana ⁱ   Capewell, Simon ^e  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c FAKULTNÍ THOMAYEROVA NEMOCNICE   (Czech Republic)

^d International Clinical Research Centre   (Czech Republic)

^e UNIVERSITY OF LIVERPOOL   (United Kingdom)

^f NEWCASTLE UNIVERSITY   (United Kingdom)

^g Institute of Health Information and Statistics of the Czech Republic   (Czech Republic)

^h UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

ⁱ INSTITUTE OF COMPUTER SCIENCE   (Czech Republic)

Author keywords

Coronary heart disease; coronary heart disease management; coronary heart disease mortality; coronary heart disease risk factors; Czech MONICA and Czech post M

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR MORTALITY; CZECH REPUBLIC; DIABETES MELLITUS; EVIDENCE BASED MEDICINE; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION; CARDIOVASCULAR RISK; HEALTH CARE POLICY; HEALTH CARE QUALITY; MAJOR CLINICAL STUDY; MORTALITY RATE; PRIMARY PREVENTION; RESUSCITATION; SECONDARY PREVENTION; SMOKING; SOCIAL STATUS; CORONARY ARTERY DISEASE; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; SENSITIVITY AND SPECIFICITY; STATISTICAL MODEL;

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

ADULT; AGED; CORONARY DISEASE; CZECH REPUBLIC; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; RISK FACTORS; SENSITIVITY AND SPECIFICITY;

EID: 84902583434     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487312469476     Document Type: Article

References (32)

1. World Health Organization. Global Atlas on Cardiovascular Disease Prevention and Control, www.who.int/cardiovascular-diseases/publications/ atlas-cvd/en/index.html (accessed September 2011).
2. Institute for Health Information and Statistics of the Czech Republic. Zemreli 2008, http://www.uzis.cz/ katalog/zdravotnicka-statistika/zemreli (accessed 2011).
3. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980- 2000. N Engl J Med 2007; 356: 2388-2398.
4. Palmieri L, Bennett K, Giampaoli S, et al. Explaining the decrease in coronary heart disease mortality in Italy between 1980 and 2000. Am J Public Health 2010; 100: 684-962.
5. Bennett K, Kabir Z, Unal B, et al. Explaining the recent decrease in coronary heart disease mortality rates in Ireland, 1985-2000. J Epidemiol Community Health 2006 60 322-327.
6. Hughes J, Kee F, OFlaherty M, et al. Modelling coronary heart disease mortality in Northern Ireland between 1987 and 2007: Broader lessons for prevention. Eur J Prev. Epub ahead of print 8 March 2012. DOI: 10.1177/2047487312441725.
7. Bjorck L, Rosengren A, Bennett K, et al. Modelling the decreasing coronary heart disease mortality in Sweden between 1986 and 2002. Eur Heart J 2009; 30: 1046-1056.
8. Unal B, Critchley JA and Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004; 109: 1101-1107.
9. Laatikainen T, Critchley J, Vartiainen E, et al. Explaining the decline in coronary heart disease mortality in Finland between 1982 and 1997. Am J Epidemiol 2005; 162: 764-773.
10. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Casecontrol study. Lancet 2004; 364: 937-952.
11. Capewell S and OFlaherty M. What explains declining coronary mortality? Lessons and warnings. Heart 2008; 94: 1105-1108.
12. Cfkova R, S kodova Z, Bruthans J, et al. Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and post-MONICA. Atherosclerosis 2010; 211: 676-681.
13. McGovern PG, Jacobs Jr DR, Shahar E, et al. Trends in acute coronary heart disease mortality, morbidity, and medical care from 1985 through 1997: The Minnesota heart survey. Circulation 2001; 104: 19-24.
14. Bruthans J. Zprava o vyvoji kardiovaskularnch onemocnen v Ceske republice po roce 1989, 1st edn. Praha: Galen, 2000.
15. Unal B, Critchley J and Capewell S. IMPACT, a validated, comprehensive coronary heart disease model. Liverpool: University of Liverpool, May 2007, http:// www.liv.ac.uk/PublicHealth/sc/bua/IMPACT- Model-%20Appendices-May-2007. pdf
16. Law MR, Wald NJ, Wu T, et al. Systematic underestimation of association between serum cholesterol concentration and ischaemic heart disease in observational studies: Data from BUPA study. BMJ 1994; 308: 363-366.
17. Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: full text, chapter 19. Eur J Cardiovasc Prev Rehabil 2007; 14(Suppl. 2): S1-S113.
18. Boden WE, ORourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007; 356: 1503-1516.
19. Cecil WT, Kasteridis P, Barnes Jr JW, et al. A metaanalysis update: Percutaneous coronary interventions. Am J Managed Care 2008; 14: 521-528.
20. Mant J and Hicks N. Detecting differences in quality of care: The sensitivity of measures of process and outcome in treating acute myocardial infarction. BMJ 1995; 311: 793-796.
21. Nichol MB, Venturini F and Sung JC. A critical evaluation of the methodology of the literature on medication compliance. Ann Pharmacother 1999; 33: 531-540.
22. Butler J, Arbogast PG, BeLue R, et al. Outpatient adherence to beta-blocker therapy after myocardial infarction. J Am Coll Cardiol 2002; 40: 1589-1595.
23. Food consumption data released by the Czech Statistical Office, http://m.czso.cz/cz/cr-1989-ts/0302.pdf (accessed 2011).
24. Ascherio A, Hennekens C, Willett WC, et al. Prospective study on nutritional factors, blood pressure, and hypertension among US women. Hypertension 1996; 27: 1065-1072.
25. Cifkova R, Skodova Z, Bruthans J, et al. Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population 1985 to 20 078/08. J Hypertens 2010; 28: 2196-2203.
26. Vecernk J and Mateju P. Ten years of rebuilding capitalism: Czech society after 1989, 1st edn. Prague: Academia, 1999.
27. Bauer T, Gitt AK, Junger C, et al. Guideline-recommended secondary prevention drug therapy after acute myocardial infarction: predictors and outcomes after non-adherence. Eur J Cardiovasc Prev Rehabil 2010; 17: 576-581.
28. Bandosz P, OFlaherty M, Drygas W, et al. Decline in mortality from coronary heart disease in Poland after socioeconomic transformation: Modelling study. BMJ 2012; 344: d8136.
29. Bots ML and Grobbee DE. Decline of coronary heart disease mortality in the Netherlands from 1978 to 1985: Contribution of medical care and changes over time in presence of major cardiovascular risk factors. J Cardiovasc Risk 1966; 3: 271-276.
30. Capewell S, Morrison CE and McMurray JJ. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and 1994. Heart 1999; 81: 380-386.
31. Vartiainen E, Puska P, Pekkanen J, et al. Changes in risk factors explain changes in mortality from ischaemic heart disease in Finland. BMJ 1994; 309: 23-27.
32. Aspelund T, Gudnason V, Magnusdottir BT, et al. Analysing the large decline in coronary heart disease mortality in the Icelandic population aged 25-74 between the years 1981 and 2006. PLoS One 2010; 5: e13957.